DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 33 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $178,000 | -44.7% | 12,295 | -62.2% | 0.03% | -50.0% |
| Q2 2016 | $322,000 | -24.8% | 32,500 | -27.8% | 0.06% | -15.2% |
| Q1 2016 | $428,000 | -23.6% | 45,000 | -10.0% | 0.07% | -9.6% |
| Q4 2015 | $560,000 | -11.1% | 50,000 | +11.1% | 0.07% | -52.3% |
| Q3 2015 | $630,000 | +7.9% | 45,000 | 0.0% | 0.15% | +109.6% |
| Q2 2015 | $584,000 | +7.0% | 45,000 | +12.5% | 0.07% | -3.9% |
| Q1 2015 | $546,000 | +37.2% | 40,000 | +14.3% | 0.08% | +20.6% |
| Q4 2014 | $398,000 | – | 35,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 194,340 | $253,000 | 0.02% |
| MIDDLETON & CO INC/MA | 15,848 | $21,000 | 0.01% |
| Acrospire Investment Management LLC | 4,220 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,942 | $26,000 | 0.00% |
| A.R.T. Advisors, LLC | 32,426 | $42,000 | 0.00% |
| FNY Partners Fund LP | 500 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 43,447 | $56,000 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 13,200 | $17,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 24,378 | $32,000 | 0.00% |
| MORGAN STANLEY | 7,566 | $10,000 | 0.00% |